Erectile Dysfunction news | Breaking erectile dysfunction news | Erectile Dysfunction

VIVUS Reports First Quarter 2007 Financial Results and Accomplishments

...MUSE(R) is approved and currently on the market for the treatment of ED.

For more information on clinical trials and products, please visit the company's web site at www.vivus.com.

Note to Investors As previously announced, VIVUS will hold a conference call to discuss the first quarter financial results today, April 26, 2007, beginning at 4:30 p.m.

Eastern Time.

You can listen to this call by dialing 1-800-573-4752, and outside the U.S.

1-617-224-4324, and entering passcode 95635542.

A live webcast and 30-day archive of the call can be accessed at http://ir.vivus.com/.

A replay of the conference call will be available beginning at 6:30 p.m.

ET on April 26, 2007 through 6:30 p.m.

ET on May 3, 2007.

Access numbers for this replay are: 1-888-286-8010 (U.S./Canada) and 1-617-801-6888 (international).

The access code for the replay is 50583319.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.

These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others.

These forward-looking statements are based on VIVUS' current expectations and actual results could differ materially.

There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements.

These factors include, but are not limited to, substantial competition;...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news